HuGE Literature Finder
Records 1-15
|
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.
Blood advances 2020 Mar 4 (6): 1038-1050. Jain Preetesh, Zhang Shaojun, Kanagal-Shamanna Rashmi, Ok Chi Young, Nomie Krystle, Gonzalez Graciela Nogueras, Gonzalez-Pagan Omarya, Hill Holly A, Lee Hun Ju, Fayad Luis, Westin Jason, Nastoupil Loretta, Hagemeister Frederick, Chen Wendy, Oriabure Onyeka, Badillo Maria, Jiang Changying, Yixin Yao, Li Shaoying, Tang Guilin, Yin C Cameron, Patel Keyur P, Medeiros Leonard Jeffrey, Nair Ranjit, Ahmed Sairah, Iyer Swaminathan P, Thirumurthi Selvi, Champlin Richard, Xu Guofan, Tinsu Pan, Santos David, Wang Ruiping, Han Guangchun, Zhang Jianhua, Song Xingzhi, Neelapu Sattva, Romaguera Jorge, Futreal Andy, Flowers Christopher, Fowler Nathan, Wang Linghua, Wang Michael |
|
Targeted next generation sequencing reveals a common genetic pathway for colorectal cancers with chromosomal instability and those with microsatellite and chromosome stability.
Pathology, research and practice 2019 May 152445. Ham-Karim Hersh A, Ebili Henry O, Bradshaw Kirsty, Richman Susan D, Fadhil Wakkas, Domingo Enric, Tomlinson Ian, Ilyas Mohamm |
|
Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group.
Genes, chromosomes & cancer 2018 Sep . Roos-Weil Damien, Nguyen-Khac Florence, Chevret Sylvie, Touzeau Cyrille, Roux Clémence, Lejeune Julie, Cosson Adrien, Mathis Stéphanie, Feugier Pierre, Leprêtre Stéphane, Béné Marie-Christine, Baron Marine, Raynaud Sophie, Struski Stéphanie, Eclache Virginie, Sutton Laurent, Lesty Claude, Merle-Béral Hélène, Cymbalista Florence, Ysebaert Loïc, Davi Frédéric, Leblond Véronique, |
|
"Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
American journal of hematology 2017 Dec . Chapiro Elise, Lesty Claude, Gabillaud Clémentine, Durot Eric, Bouzy Simon, Armand Marine, Le Garff-Tavernier Magali, Bougacha Nadia, Struski Stéphanie, Bidet Audrey, Laharanne Elodie, Barin Carole, Veronese Lauren, Prié Nolwen, Eclache Virginie, Gaillard Baptiste, Michaux Lucienne, Lefebvre Christine, Gaillard Jean-Baptiste, Terré Christine, Penther Dominique, Bastard Christian, Nadal Nathalie, Fert-Ferrer Sandra, Auger Nathalie, Godon Catherine, Sutton Laurent, Tournilhac Olivier, Susin Santos A, Nguyen-Khac Florence, |
|
Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.
Genes, chromosomes & cancer 2017 Nov . Oltmann Johanna, Heselmeyer-Haddad Kerstin, Hernandez Leanora S, Meyer Rüdiger, Torres Irianna, Hu Yue, Doberstein Natalie, Killian J Keith, Petersen David, Zhu Y Jack, Edelman Daniel C, Meltzer Paul S, Schwartz Russell, Gertz E Michael, Schäffer Alejandro A, Auer Gert, Habermann Jens K, Ried Thom |
|
Genomic Classification and Prognosis in Acute Myeloid Leukemia.
The New England journal of medicine 2016 Jun 374 (23): 2209-21. Papaemmanuil Elli, Gerstung Moritz, Bullinger Lars, Gaidzik Verena I, Paschka Peter, Roberts Nicola D, Potter Nicola E, Heuser Michael, Thol Felicitas, Bolli Niccolo, Gundem Gunes, Van Loo Peter, Martincorena Inigo, Ganly Peter, Mudie Laura, McLaren Stuart, O'Meara Sarah, Raine Keiran, Jones David R, Teague Jon W, Butler Adam P, Greaves Mel F, Ganser Arnold, Döhner Konstanze, Schlenk Richard F, Döhner Hartmut, Campbell Peter |
|
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
Oncotarget 2016 Apr . Suraweera Nirosha, Mouradov Dmitri, Li Shan, Jorissen Robert N, Hampson Debbie, Ghosh Anil, Sengupta Neel, Thaha Mohamed, Ahmed Shafi, Kirwan Michael, Aleva Floor, Propper David, Feakins Roger M, Vulliamy Tom, Elwood Ngaire J, Tian Pei, Ward Robyn L, Hawkins Nicholas J, Xu Zheng-Zhou, Molloy Peter L, Jones Ian T, Croxford Matthew, Gibbs Peter, Silver Andrew, Sieber Oliver |
|
Aberrations of BUBR1 and TP53 gene mutually associated with chromosomal instability in human colorectal cancer.
Anticancer research 2014 Oct 34 (10): 5421-7. Zhao Yan, Ando Koji, Oki Eiji, Ikawa-Yoshida Ayae, Ida Satoshi, Kimura Yasue, Saeki Hiroshi, Kitao Hiroyuki, Morita Masaru, Maehara Yoshihi |
|
B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Hematological oncology 2014 Mar 32 (1): 22-30. Falisi Erika, Novella Elisabetta, Visco Carlo, Guercini Nicola, Maura Francesco, Giaretta Ilaria, Pomponi Fabrizio, Nichele Ilaria, Finotto Silvia, Montaldi Annamaria, Neri Antonino, Rodeghiero Frances |
|
Somatic changes in primary liver cancer in Russia: a pilot study.
Mutation research 2013 Aug 755 (2): 90-9. Kalinina Olga, Marchio Agnès, Urbanskii Aleksandr I, Tarkova Aleksandra B, Rebbani Khadija, Granov Dmitri A, Dejean Anne, Generalov Mikhail I, Pineau Pasc |
|
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.
Blood 2013 Jan 121 (3): 468-75. Oscier David G, Rose-Zerilli Matthew J J, Winkelmann Nils, Gonzalez de Castro David, Gomez Belen, Forster Jade, Parker Helen, Parker Anton, Gardiner Anne, Collins Andrew, Else Monica, Cross Nicholas C P, Catovsky Daniel, Strefford Jonathan |
|
Maternal SNPs in the p53 pathway: Risk factors for trisomy 21?
Disease markers 2012 Oct . Boquett JA, Brandalize AP, Fraga LR, Schuler-Faccini L |
|
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.
Neuro-oncology 2011 Feb 13 (2): 235-41. Taal Walter, Dubbink Hendrikus J, Zonnenberg Chris B L, Zonnenberg Bernard A, Postma Tjeerd J, Gijtenbeek Johanna M M, Boogerd Willem, Groenendijk Floris H, Kros Johan M, Kouwenhoven Mathilde C M, van Marion Ronald, van Heuvel Irene, van der Holt Bronno, Bromberg Jacoline E C, Sillevis Smitt Peter A E, Dinjens Winand N M, van den Bent Martin J, |
|
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
PLoS medicine 2007 Feb 4 (2): e67. Galipeau Patricia C, Li Xiaohong, Blount Patricia L, Maley Carlo C, Sanchez Carissa A, Odze Robert D, Ayub Kamran, Rabinovitch Peter S, Vaughan Thomas L, Reid Brian |
|
Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma.
Cancer letters 2003 Oct 200 (2): 149-52. Lipton Lara, Fleischmann Christina, Sieber Oliver M, Thomas Huw J W, Hodgson Shirley V, Tomlinson Ian P M, Houlston Richard |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: